author-photo

Margalit B. Mokyr

University of Illinois at Chicago

86

Papers

1641

Citations

Citation Trend

Filter By

Papers (61) Sort By

Journal Conference Others

Abstract 4755: Importance of an induction dose to the immunogenicity of cancer vaccines: A reverse translational study

2010 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
The Xeroderma Pigmentosum Group E Gene Product DDB2 Activates Nucleotide Excision Repair by Regulating the

2008
Show All
- Source
- Cite
- Save
Citations (4)
The Xeroderma Pigmentosum Group E Gene Product DDB2 Activates Nucleotide Excision Repair by Regulating the Level of p21Waf1/Cip1

2008 Molecular and Cellular Biology
Show All
- Source
- Cite
- Save
Citations (48)
Talactoferrin alfa is an anti-cancer agent with activity in renal cell cancer (RCC) patients and a novel immunomodulatory mechanism of action

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Talactoferrin Alfa, a novel immunomodulatory agent with anti-cancer activity in phase II clinical trials.

2006 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Importance of IL-10 for CTLA-4-Mediated Inhibition of Tumor-Eradicating Immunity

2004 Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (43)
Melphalan-induced up-regulation of B7–1 surface expression on normal splenic B cells

2003 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (15)
Anti-metastatic activity of hapten-modified autologous tumor cell vaccine in an animal tumor model

2002 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (11)
Melphalan-Induced Expression of IFN-β in MOPC-315 Tumor-Bearing Mice and Its Importance for the Up-Regulation of TNF-α Expression

2001 Journal of Immunology
- Vladimir Jovasevic
- Margalit B. Mokyr
Show All
- Source
- Cite
- Save
Citations (15)
Melphalan and Other Anticancer Modalities Up-Regulate B7-1 Gene Expression in Tumor Cells

2000 Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (53)